SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-010746
Filing Date
2022-03-04
Accepted
2022-03-04 16:01:13
Documents
4
Period of Report
2022-03-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea156507-6k_altamira.htm 6-K 17412
2 LICENSING & DISTRIBUTION AGREEMENT, DATED FEBRUARY 28, 2022, BY AND BETWEEN ALTA ea156507ex10-1_altamira.htm EX-10.1 193253
3 PRESS RELEASE, DATED MARCH 4, 2022 ea156507ex99-1_altamira.htm EX-99.1 15859
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3929
  Complete submission text file 0001213900-22-010746.txt   233426
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 22713961
SIC: 2834 Pharmaceutical Preparations